EUVIMEDEUVIMED entdecken
Leserbrief

Dupilumab Add‐On Therapy in Severe Refractory Darier Disease

Nedim Uysal iD, Anıl Çağrı Tuna iD, Ayşenur Botsalı iD

International Journal of Dermatology · 14.07.2026

DOI: 10.1111/ijd.70583 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 14.07.2026. Verfasst von Nedim Uysal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Gülhane Training and Research Hospital, Ankara, Türkiye. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Darier diseaseacitretindupilumabmethicillin‐resistant Staphylococcus aureuspruritus

Autor:innen und Institutionen

  • Dermatology Department, Gülhane Training and Research Hospital, Ankara, Türkiye.

ORCID-Profile: Nedim Uysal, Anıl Çağrı Tuna, Ayşenur Botsalı

Zitieren

APA

Uysal, N., Tuna, A. Ç., & Botsalı, A. (2026). Dupilumab Add‐On Therapy in Severe Refractory Darier Disease. International Journal of Dermatology. https://doi.org/10.1111/ijd.70583

Vancouver

Uysal N, Tuna AÇ, Botsalı A. Dupilumab Add‐On Therapy in Severe Refractory Darier Disease. International Journal of Dermatology. 2026. doi:10.1111/ijd.70583

BibTeX
@article{Uysal2026,
  author = {Uysal, Nedim and Tuna, Anıl Çağrı and Botsalı, Ayşenur},
  title = {Dupilumab Add‐On Therapy in Severe Refractory Darier Disease},
  journal = {International Journal of Dermatology},
  year = {2026},
  doi = {10.1111/ijd.70583}
}
Kostenlos starten →